Actively Recruiting
GWA Study in Patients With Inflammatory Bowel Disease
Led by Chinese University of Hong Kong · Updated on 2023-02-08
3600
Participants Needed
1
Research Sites
1408 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to identify new genes in Chinese patients that help investigators to understand the biological pathway and functions in a population in whom the incidence of Inflammatory Bowel Disease (IBD) is increasing. And to explore the genetic variations in Chinese patients with IBD.
CONDITIONS
Official Title
GWA Study in Patients With Inflammatory Bowel Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 or above
- Informed consent given by patient or family
- Diagnosis of Crohn's disease or ulcerative colitis confirmed by endoscopy, radiology and histology for case group
- Control group matched by sex and age attending clinics or endoscopy for functional upper gastrointestinal diseases or screening colonoscopy
You will not qualify if you...
- No consent given
- Controls previously diagnosed with inflammatory bowel disease
- Controls with a first or second degree relative diagnosed with inflammatory bowel disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prince of Wales Hospital
Hong Kong, Hong Kong
Actively Recruiting
Research Team
S
Siew C NG, PhD
CONTACT
K
Kim W AU, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here